The Pharmaceutical Benefits Advisory Committee (PBAC) has three (3) main cycles per year where it considers applications for funding of new medicines and vaccines. For most items on a meeting agenda, there is an eight (8) week consultation period. 

Learn more about the PBAC and the PBS and stay in touch by subscribing to the PBS news.

PBAC meeting agenda and consultation dates

Information on key dates and documents for the PBAC meetings

Open PBAC consultations for feedback

  • Public consultation on items to be considered by the PBAC (November 2024)

    Consultation has opened for the November 2024 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence...

    Closes 25 September 2024